Effect of hyperthermia and proton beam radiation as a novel approach in chordoma cells death and its clinical implication to treat chordoma

References

• Berger MJ, Coursey JS, Zucker MA, Chang J. 2005. ESTAR J, PSTAR, and ASTAR: computer programs for calculating stopping-power and range tables for electrons, protons, and helium ions (version 2.0.1). Gaithersburg, MD. Available online at: http://physics.nist.gov/Star.
   Google Scholar
• Casali PG, Stacchiotti S, Sangalli C, Olmi P, Gronchi A. 2007. Chordoma. Curr Opin Oncol. 19(4):367–370.
   PubMed Web of Science ®Google Scholar
• Chordoma Foundation. 2019. Treatment – Chordoma Foundation https://www.chordomafoundation.org/treatment/
   Google Scholar
• Chordoma Foundation. 2020. Understanding Chordoma. https://www.chordomafoundation.org/understanding-chordoma/
   Google Scholar
• Datta NR, Schneider R, Puric E, Ahlhelm FJ, Marder D, Bodis S, Weber DC. 2016. Proton irradiation with hyperthermia in unresectable soft tissue sarcoma. Int J Part Ther. 3(2):327–336.
   PubMedGoogle Scholar
• Davey HS, Harvie MW, Davey RA. 2002. Fractionated irradiation of H69 small‐cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase II alpha expression. Int J Radiat Oncol Biol Phys. 54:895–902.
   PubMed Web of Science ®Google Scholar
• Desouky O, Ding N, Zhou G. 2015. Targeted and non-targeted effects of ionizing radiation. J Radiat Res Appl Sci. 8(2):247–254.
   Web of Science ®Google Scholar
• Dewey WC. 2009. Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperthermia. 25(1):3–20.
   PubMed Web of Science ®Google Scholar
• Eriksson D, Stigbrand T. 2010. Radiation-induced cell death mechanisms. Tumour Biol. 31(4):363–372.
   PubMedGoogle Scholar
• Foltyn M, Luger A-L, Lorenz NI, Sauer B, Mittelbronn M, Harter PN, Steinbach JP, Ronellenfitsch MW. 2019. The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma. Br J Cancer. 120(5):481–487.
   PubMed Web of Science ®Google Scholar
• Franken NAP, Oei AL, Kok HP, Rodermond HM, Sminia P, Crezee J, Stalpers LJA, Barendsen GW. 2013. Cell survival and radiosensitisation: modulation of the linear and quadratic parameters of the LQ model (review). Int J Oncol. 42(5):1501–1515.
   PubMed Web of Science ®Google Scholar
• Hada M, Georgakilas A. 2008. Formation of clustered DNA damage after high-LET irradiation: a review. J Radiat Res. 49(3):203–210.
   PubMed Web of Science ®Google Scholar
• Hall EJ, Giaccia AJ. 2018. Radiobiology for the radiologist. 8th ed. Philadelphia (PA): Wolters Kluwer.
   Google Scholar
• Heery C. 2016. Chordoma: the quest for better treatment options. Oncol Ther. 4(1):35–51.
   PubMed Web of Science ®Google Scholar
• Heery CR, Singh BH, Rauckhorst M, Marté JL, Donahue RN, Grenga I, Rodell TC, Dahut W, Arlen PM, Madan RA, et al. 2015. Phase I trial of a yeast-based therapeutic cancer vaccine (GI-6301) targeting the transcription factor brachyury. Cancer Immunol Res. 3(11):1248–1256.
   PubMed Web of Science ®Google Scholar
• Hojo H, Dohmae T, Hotta K, Kohno R, Motegi A, Yagishita A, Makinoshima H, Tsuchihara K, Akimoto T. 2017. Difference in the relative biological effectiveness and DNA damage repair processes in response to proton beam therapy according to the positions of the spread out Bragg peak . Radiat Oncol. 12(1):111.
   PubMedGoogle Scholar
• Hsu W, Mohyeldin A, Shah SR, Ap Rhys CM, Johnson LF, Sedora-Roman NI, Kosztowski TA, Awad OA, McCarthy EF, Loeb DM, et al. 2011. Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target. J Neurosurg. 115(4):760–769.
   PubMed Web of Science ®Google Scholar
• Hu Y, Mintz A, Shah SR, Quinones-Hinojosa A, Hsu W. 2014. The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival. Carcinogenesis. 35(7):1491–1499.
   PubMed Web of Science ®Google Scholar
• IJff M, Van Oorschot B, Oei AL, Krawczyk PM, Rodermond HM, Stalpers LJA, Kok HP, Crezee J, Franken NAP. 2018. Enhancement of radiation effectiveness in cervical cancer cells by combining ionizing radiation with hyperthermia and molecular targeting agents. Int J Mol Sci. 19(8):2420.
   Web of Science ®Google Scholar
• Indelicato DJ, Rotondo RL, Begosh-Mayne D, Scarborough MT, Gibbs CP, Morris CG, Mendenhall WM. 2016. A prospective outcomes study of proton therapy for chordomas and chondrosarcomas of the spine. Int J Radiat Oncol Biol Phys. 95(1):297–303.
   PubMed Web of Science ®Google Scholar
• Jian J, Zhong N, Jiang D, Li L, Lou Y, Zhou W, Chen S, Xiao J. 2018. The embryonic transcription factor Brachyury confers chordoma chemoresistance via upregulating CA9. Am J Transl Res. 10(3):936–947.
   PubMed Web of Science ®Google Scholar
• Juang T, Stauffer PR, Craciunescu OA, Maccarini PF, Yuan Y, Das SK, Dewhirst MW, Inman BA, Vujaskovic Z. 2014. Thermal dosimetry characteristics of deep regional heating of non-muscle invasive bladder cancer. Int J Hyperthermia. 30(3):176–183.
   PubMed Web of Science ®Google Scholar
• Kampinga HH, Dikomey E. 2001. Hyperthermia radiosensitization: mode of action and clinical relevance. Int J Radiat Biol. 77(4):388–401.
   Web of Science ®Google Scholar
• Kaur P, Hurwitz MD, Krishnan S, Asea A. 2011. Combined hyperthermia and radiotherapy for the treatment of cancer. Cancers. 3(4):3799–3823.
   PubMedGoogle Scholar
• Kaver I, Ware JL, Wilson JD, Koontz WW. 1991. Effect of radiation combined withhyperthermia on human prostatic carcinoma cell lines in culture. Urology. 38(1):88–92.
   PubMed Web of Science ®Google Scholar
• Krawczyk PM, Eppink B, Essers J, Stap J, Rodermond H, Odijk H, Zelensky A, van Bree C, Stalpers LJ, Buist MR, et al. 2011. Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition. Proceedings of the National Academy of Sciences. 108(24):9851–9856.
   PubMed Web of Science ®Google Scholar
• Kumari S, Mukherjee S, Sinha D, Abdisalaam S, Krishnan S, Asaithamby A. 2020. Immunomodulatory effects of radiotherapy. Int J Mol Sci. 21(21):8151.
   Web of Science ®Google Scholar
• Lee S, Szigeti G, Szasz A. 2019. Oncological hyperthermia: the correct dosing in clinical applications. Int J Oncol. 54(2):627–643.
   PubMed Web of Science ®Google Scholar
• Mahmood J, Alexander AA, Samanta S, Kamlapurkar S, Singh P, Saeed A, Carrier F, Cao X, Shukla HD, Vujaskovic Z, et al. 2020. A combination of radiotherapy, hyperthermia, and immunotherapy inhibits pancreatic tumor growth and prolongs the survival of mice. Cancers. 12(4):1015.
   Web of Science ®Google Scholar
• Michaelidesová A, Vachelová J, Puchalska M, Brabcová KP, Vondráček V, Sihver L, Davídková M. 2017. Relative biological effectiveness in a proton spread-out Bragg peak formed by pencil beam scanning mode. Australas Phys Eng Sci Med. 40(2):359–368.
   PubMed Web of Science ®Google Scholar
• Min K-J, Woo SM, Shahriyar SA, Kwon TK. 2019. Elucidation for modulation of death receptor (DR) 5 to strengthen apoptotic signals in cancer cells. Arch Pharm Res. 42(1):88–100.
   PubMed Web of Science ®Google Scholar
• Molitoris JK, Rodrigues D, Snider JW, Sharma AM, Mossahebi S, Zakhary M, Lehman K, Vujaskovic Z. 2019. Deep locoregional thermal therapy concurrent with pencil beam scanning proton therapy: initial report of safety and feasibility. Int. J Radiation Oncol, Biol Phys. 105(1):S243.
   Web of Science ®Google Scholar
• Multhoff G, Pockley AG, Schmid TE, Schilling D. 2015. The role of heat shock protein 70 (Hsp70) in radiation-induced immunomodulation. Cancer Lett. 368(2):179–184.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. 2020. Hyperthermia in cancer treatment. https://www.cancer.gov/about-cancer/treatment/types/surgery/hyperthermia-fact-sheet
   Google Scholar
• Nibu Y, José-Edwards D, Di Gregorio A. 2013. From notochord formation to hereditary chordoma: the many roles of Brachyury. Biomed Res Int. 2013:826435–826414.
   PubMed Web of Science ®Google Scholar
• Oei AL, Korangath P, Mulka K, Helenius M, Coulter JB, Stewart J, Velarde E, Crezee J, Simons B, Stalpers LJA. 2019. Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer. Int J Hyperthermia. 36(sup1):47–63.
   PubMed Web of Science ®Google Scholar
• Oei AL, Vriend LEM, Crezee J, Franken NAP, Krawczyk PM. 2015. Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all. Radiat Oncol. 10:165.
   PubMed Web of Science ®Google Scholar
• O’Neill BE, Vo H, Angstadt M, Li KP, Quinn T, Frenkel V. 2009. Pulsed high intensity focused ultrasound mediated nanoparticle delivery: mechanisms and efficacy in murine muscle. Ultrasound Med Biol. 35(3):416–424.
   PubMed Web of Science ®Google Scholar
• Otani R, Mukasa A, Shin M, Omata M, Takayanagi S, Tanaka S, Ueki K, Saito N. 2018. Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma. J Neurosurg. 128(5):1428–1437.
   PubMed Web of Science ®Google Scholar
• Paganetti H. 2014. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys Med Biol. 59(22):R419–R472.
   PubMed Web of Science ®Google Scholar
• QUILT-3.011. 2019. Phase 2 yeast-brachyury vaccine chordoma. https://clinicaltrials.gov/ct2/show/record/NCT02383498?view=record
   Google Scholar
• Raoof M, Zhu C, Cisneros BT, Liu H, Corr SJ, Wilson LJ, Curley SA. 2014. Hyperthermia inhibits recombination repair of gemcitabine-stalled replication forks. J Natl Cancer Inst. 106(8)dju183.
   PubMedGoogle Scholar
• Saager M, Peschke P, Brons S, Debus J, Karger CP. 2018. Determination of the proton RBE in the rat spinal cord: is there an increase towards the end of the spread-out Bragg peak? Radiother Oncol. 128(1):115–120.
   PubMed Web of Science ®Google Scholar
• Salahi S, Maccarini PF, Rodrigues DB, Etienne W, Landon CD, Inman BA, Dewhirst MW, Stauffer PR. 2012. Miniature microwave applicator for murine bladder hyperthermia studies. Int J Hyperthermia. 28(5):456–465.
   PubMed Web of Science ®Google Scholar
• Sapareto SA, Dewey WC. 1984. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys. 10(6):787–800.
   PubMed Web of Science ®Google Scholar
• Sun X, Hornicek F, Schwab J. 2015. Chordoma: an update on the pathophysiology and molecular mechanisms. Curr Rev Musculoskelet Med. 8(4):344–352.
   PubMed Web of Science ®Google Scholar
• Tran S, Puric E, Walser M, Poel R, Datta NR, Heuberger J, Pica A, Marder D, Lomax N, Bolsi A, et al. 2020. Early results and volumetric analysis after spot-scanning proton therapy with concomitant hyperthermia in large inoperable sacral chordomas. Br J Radiol. 93(1107):20180883.
   PubMed Web of Science ®Google Scholar
• van der Zee J. 2002. Heating the patient: a promising approach? Ann Oncol. 13(8):1173–1184.
   PubMed Web of Science ®Google Scholar
• van Rhoon GC. 2016. Is CEM43 still a relevant thermal dose parameter for hyperthermia treatment monitoring? Int J Hyperthermia. 32(1):50–62.
   PubMed Web of Science ®Google Scholar
• von Witzleben A, Goerttler LT, Marienfeld R, Barth H, Lechel A, Mellert K, Böhm M, Kornmann M, Mayer-Steinacker R, von Baer A, et al. 2015. Preclinical characterization of novel chordoma cell systems and their targeting by pharmocological inhibitors of the CDK4/6 cell-cycle pathway. Cancer Res. 75(18):3823–3831.
   PubMed Web of Science ®Google Scholar
• Vujovic S, Henderson S, Presneau N, Odell E, Jacques TS, Tirabosco R, Boshoff C, Flanagan AM. 2006. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol. 209(2):157–165.
   PubMed Web of Science ®Google Scholar
• Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag PM. 2002. Hyperthermia in combined treatment of cancer. Lancet Oncol. 3(8):487–497.
   PubMed Web of Science ®Google Scholar
• Yang XR, Ng D, Alcorta DA, Liebsch NJ, Sheridan E, Li S, Goldstein AM, Parry DM, Kelley MJ. 2009. TBXT (brachyury) gene duplication confers major susceptibility to familial chordoma. Nat Genet. 41(11):1176–1178.
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang B, Li L, Li Y, Li P, Lv G. 2017. Radioresistance of chordoma cells is associated with the ATM/ATR pathway, in which RAD51 serves as an important downstream effector. Exp Ther Med. 14(3):2171–2179.
   PubMed Web of Science ®Google Scholar